Chickasaw Capital Management LLC acquired a new position in shares of UnitedHealth Group Inc (NYSE:UNH) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 1,150 shares of the healthcare conglomerate’s stock, valued at approximately $306,000.

Several other hedge funds also recently made changes to their positions in UNH. Summit Trail Advisors LLC grew its position in shares of UnitedHealth Group by 19,286.4% during the 1st quarter. Summit Trail Advisors LLC now owns 6,228,065 shares of the healthcare conglomerate’s stock worth $6,228,000 after buying an additional 6,195,939 shares during the period. FMR LLC grew its position in shares of UnitedHealth Group by 5.1% during the 2nd quarter. FMR LLC now owns 61,622,355 shares of the healthcare conglomerate’s stock worth $15,118,428,000 after buying an additional 2,981,233 shares during the period. Vontobel Asset Management Inc. acquired a new stake in shares of UnitedHealth Group during the 2nd quarter worth approximately $404,980,000. Bank of Montreal Can acquired a new stake in shares of UnitedHealth Group during the 2nd quarter worth approximately $381,555,000. Finally, Janus Henderson Group PLC grew its position in shares of UnitedHealth Group by 61.7% during the 2nd quarter. Janus Henderson Group PLC now owns 3,525,090 shares of the healthcare conglomerate’s stock worth $864,869,000 after buying an additional 1,345,083 shares during the period. 85.35% of the stock is owned by institutional investors.

Shares of UNH opened at $266.81 on Friday. UnitedHealth Group Inc has a 12-month low of $202.70 and a 12-month high of $272.81. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 0.63. The firm has a market capitalization of $256.06 billion, a P/E ratio of 26.50, a PEG ratio of 1.58 and a beta of 0.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.30 by $0.11. UnitedHealth Group had a return on equity of 22.79% and a net margin of 5.55%. The company had revenue of $56.56 billion for the quarter, compared to analysts’ expectations of $56.34 billion. During the same period last year, the business earned $2.66 EPS. UnitedHealth Group’s quarterly revenue was up 12.4% compared to the same quarter last year. As a group, sell-side analysts forecast that UnitedHealth Group Inc will post 12.72 earnings per share for the current fiscal year.

In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 10,000 shares of the firm’s stock in a transaction on Wednesday, August 8th. The stock was sold at an average price of $258.83, for a total transaction of $2,588,300.00. Following the transaction, the director now directly owns 77,172 shares in the company, valued at approximately $19,974,428.76. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Richard T. Burke sold 15,000 shares of the firm’s stock in a transaction on Wednesday, August 1st. The shares were sold at an average price of $254.79, for a total value of $3,821,850.00. The disclosure for this sale can be found here. Over the last quarter, insiders sold 94,568 shares of company stock worth $24,950,027. 0.87% of the stock is owned by company insiders.

Several analysts have recently commented on the stock. Argus raised their price objective on shares of UnitedHealth Group to $285.00 and gave the stock a “buy” rating in a research report on Thursday. BMO Capital Markets raised their price objective on shares of UnitedHealth Group to $310.00 and gave the stock an “outperform” rating in a research report on Thursday. Leerink Swann reaffirmed an “outperform” rating on shares of UnitedHealth Group in a research report on Wednesday, July 18th. Raymond James raised their price objective on shares of UnitedHealth Group from $285.00 to $304.00 and gave the stock a “strong-buy” rating in a research report on Monday, September 24th. Finally, ValuEngine downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 11th. One investment analyst has rated the stock with a hold rating, twenty-three have assigned a buy rating and one has assigned a strong buy rating to the stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $289.41.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: Book Value Of Equity Per Share – BVPS Explained

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.